Functional and Circulating Indicators of Endothelial Health and Their Associations With the American Heart

James R Cirillo1, Kristen T Stopfer1, Mia K DeCataldo1

  • 1Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA (JRC, KTS, MKD, ALM, MRS, PJG).

Insights

The American Heart Association's Life's Essential 8 (LE8) measures cardiovascular disease risk. Lower LE8 scores correlate with increased cellular adhesion molecules, while higher scores indicate better endothelial function in midlife adults.

Area of Science:

  • Cardiovascular Health
  • Endothelial Function
  • Public Health

Background:

  • The American Heart Association's Life's Essential 8 (LE8) assesses cardiovascular disease (CVD) risk through biological and behavioral factors.
  • The relationship between LE8 scores and endothelial function, a key factor in CVD, remains largely unexamined.

Purpose of the Study:

  • To investigate the association between LE8 scores and markers of endothelial function in midlife adults.
  • To explore how LE8 components relate to forearm blood flow (FBF) and cellular adhesion molecules (VCAM-1, ICAM-1).

Main Methods:

  • 318 midlife adults (mean age 42.3 years) were assessed for LE8 components, including glucose, cholesterol, blood pressure, BMI, diet, smoking, and sleep.
  • Endothelial function was measured using forearm blood flow (FBF) during reactive hyperemia and circulating levels of VCAM-1 and ICAM-1.

Main Results:

  • Lower LE8 scores were significantly associated with higher concentrations of ICAM-1 (r = -0.41, P < 0.001).
  • Higher LE8 scores were linked to a greater FBF increase during reactive hyperemia (r = 0.29, P < 0.001), indicating improved endothelial function.
  • No significant association was found between LE8 scores and VCAM-1 levels (r = -0.06, P > 0.05).

Conclusions:

  • LE8 scores are associated with both cellular and functional markers of endothelial activity in healthy midlife adults.
  • Findings suggest LE8 may serve as a useful tool for assessing subclinical vascular health.
  • Further longitudinal research is required to clarify divergent associations with ICAM-1/VCAM-1 and predict future CVD risk.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
518
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
758
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
737
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
197
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
434
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293